Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFIF.L Regulatory News (FIF)

  • There is currently no data for FIF

Director/PDMR Shareholding

12 Jul 2011 07:00

FINSBURY FOOD GROUP PLC

11 JULY 2011

DIRECTORS DEALINGS AND GRANT OF SHARE OPTIONS

TOTAL VOTING RIGHTS

Purchase of Shares

The Company is very pleased to announce that on 8 July 2011 Stephen Boyd, Group Finance Director, subscribed for 476,190 new ordinary shares in the Company (0.89% of the enlarged share capital). Crawford Currie, Lightbody Cake subsidiary Finance Director, also subscribed for 95,238 new ordinary shares in the Company (0.18% of the enlarged share capital), each at 21 pence per share, as part of their remuneration arrangements.

Following the issue, Stephen Boyd will have a beneficial interest in 476,190 shares, representing 0.89% of the enlarged share capital, and Crawford Currie will have a beneficial interest in 95,238 shares, representing 0.18% of the enlarged share capital.

Application has been made for 571,428 ordinary shares in the Company to be admitted to trading on the AIM market of the London Stock Exchange.

Grant of Options

In addition, on 8th July 2011 the Board granted to the following directors options in terms of the Finsbury Food Group Long Term 2006 Incentive Plan:

John Duffy: options over 2,500,000 new ordinary shares of 1p each in the capital of the Company, all of which are granted in terms of the Unapproved part of the Plan with an exercise price of 20.5p per share.

Stephen Boyd: options over 2,900,000 new ordinary shares of 1p each in the capital of the Company. Of those options 146,341 were granted in terms of the Approved part of the Plan with an exercise price of 20.5p per share and 2,753,659 options were granted in terms of the Unapproved part of the Plan with an exercise price of 20.5p per share.

Crawford Currie: options over 1,071,429 new ordinary shares of 1p each in the capital of the Company. Of those options 146,341 were granted in terms of the Approved part of the Plan with an exercise price of 20.5p per share and 925,088 options were granted in terms of the Unapproved part of the Plan with an exercise price of 20.5p per share. Any options Crawford Currie held, prior to this award are considered lapsed.

Vesting of these options is subject to various conditions being met, but in each case, half of these options may vest prior to 30th September 2011 and the balance may vest in two equal tranches on 30th June 2012 and 30th June 2013. The Final exercise date is 30th October 2016.

Total Voting Rights

Following the issue of the 571,428 ordinary shares in the Company, the total number of ordinary shares of 1p each in the capital of the Company in issue as at the date of this notice is 53,359,894 with each share carrying the right to one vote. The Company holds no shares in treasury, and therefore, the total number of voting rights in the Company is 53,359,894.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FSA's Disclosure and Transparency Rules.

XLON
Date   Source Headline
21st Feb 20227:01 amRNSIncreased Stake in European Distribution Business
21st Feb 20227:00 amRNSInterim Results
13th Jan 20227:00 amRNSPre-Close Trading Statement and Notice of Results
18th Nov 20213:29 pmRNSResult of AGM
18th Nov 20217:00 amRNSAGM Statement
2nd Nov 20217:00 amRNSExecutive LTIP - PDMR Dealings
26th Oct 20217:00 amRNSAnnual Bonus Scheme – PDMR Dealings
18th Oct 20217:00 amRNSAnnual Report and Accounts and Notice of AGM
27th Sep 20215:52 pmRNSHolding(s) in Company
23rd Sep 20214:46 pmRNSDividend Timetable
20th Sep 20217:00 amRNSPreliminary Results
16th Sep 20217:00 amRNSNotice of Investor Presentation
14th Jul 20217:00 amRNSTrading Update
26th May 20217:00 amRNSTrading Update
12th May 20219:27 amRNSHolding(s) in Company
10th May 20217:00 amRNSEBT Share Purchase
22nd Feb 20217:00 amRNSInterim Results
14th Jan 20217:00 amRNSPre-Close Trading Statement and Notice of Results
12th Jan 20217:00 amRNSAppointment of NOMAD and sole broker
19th Nov 202010:40 amRNSResult of AGM
19th Nov 20207:00 amRNSAGM Statement
5th Nov 20205:36 pmRNSHolding(s) in Company
3rd Nov 202010:56 amRNSEBT Share Purchase
23rd Oct 202012:00 pmRNSExecutive LTIP - PDMR Dealings
19th Oct 20207:00 amRNSAnnual Report and Accounts and Notice of AGM
22nd Sep 20207:00 amRNSDirector/PDMR Shareholdings
21st Sep 20207:00 amRNSPreliminary Results
15th Jul 20207:00 amRNSPre-Close Trading Update and COVID-19 Statement
5th May 20209:07 amRNSHolding(s) in Company
3rd Apr 202010:00 amRNSHolding(s) in Company
27th Mar 20207:00 amRNSTrading and COVID-19 Update
25th Mar 20209:54 amRNSHolding(s) in Company
24th Feb 202012:54 pmRNSHolding(s) in Company
24th Feb 20207:00 amRNSInterim Results
21st Jan 20204:42 pmRNSHolding(s) in Company
16th Jan 20207:00 amRNSPre-Close Trading Statement and Notice of Results
10th Jan 20205:02 pmRNSExecutive LTIP Option Exercises - PDMR Dealings
2nd Jan 20209:46 amRNSHolding(s) in Company
28th Nov 201912:55 pmRNSHolding(s) in Company
20th Nov 201911:17 amRNSResult of AGM
20th Nov 20197:00 amRNSAGM Statement
30th Oct 201912:54 pmRNSReplacement: Executive LTIP - PDMR Dealings
30th Oct 20197:00 amRNSExecutive LTIP - PDMR Dealings
18th Oct 20197:00 amRNSAnnual Report and Accounts and Notice of AGM
20th Sep 20193:07 pmRNSHolding(s) in Company
16th Sep 20197:00 amRNSPreliminary Results
15th Jul 20197:00 amRNSPre-Close Trading Statement
11th Jul 20193:11 pmRNSHolding(s) in Company
25th Jun 20191:34 pmRNSHolding(s) in Company
31st May 20197:00 amRNSChange of Auditor

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.